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http:WHAT THIS PAPER ADDS
Failure after EVAR is most often associated with loss of seal and consequent re-pressurisation of the aneurysm
sac. This study explores the evolution of the iliac seal zones after implantation, showing that progressive
dilatation and retraction are very common occurrences, which in turn have clinical consequences. Careful
attention to planning to take full advantage of the potential iliac seal, avoidance of “bell-bottom” limbs
whenever possible, and attention to signs of excessive dilatation and/or retraction over the course of follow-up
are practical recommendations derived from the conclusions of this study that may improve outcomes.Objective: To evaluate the dynamics of the iliac attachment zone after EVAR, and the association with clinical
events.
Methods: A tertiary institution’s prospective EVAR database was searched to identify common iliac arteries at
risk. Internally validated measurements were made, using centre lumen line reconstructions. Iliac dilatation and
endograft limb retraction were the main endpoints. Associations between dilatation, retraction, oversizing, and
distal seal length were investigated. Association with clinical events (sealing or occlusion) was also explored.
Results: Of 452 primary EVAR patients treated from 2004 to 2012, 341 were included (mean age 72 years, 12%
female, 597 common iliac arteries). Median follow-up was 4.7 years. At 30 days, the mean iliac diameter
increased from 14 mm to 15 mm (p < .001). Over follow-up, it increased to 18 mm (p < .001). Iliac dilatation
20% occurred in 295 cases (49.4%) and exceeded the implanted endograft diameter in 170 (28.7%). Limb
retraction 5 mm was identiﬁed in 54 patients (9.1%) and was associated with iliac seal complications
(p < 0.001). Iliac endograft extension diameter 24 mm (OR 3.3, 95% CI 1.7e6.4) and iliac artery dilatation
beyond the endograft (OR 2.1, 95% CI 1.2e3.8) were independent risk factors. Overall, there were 34 (5.7%) iliac
seal complications. Retraction of the iliac endograft (OR 1.17 per mm, 95% CI 1.10e1.24) and baseline AAA
diameter (1.04 per mm, 95% CI 1.01e1.07) were independent risk factors for seal related complications. Greater
initial post-operative iliac seal length was protective (OR 0.94 per mm, 95% CI 0.90e0.97).
Conclusions: Iliac dilatation and endograft retraction are common ﬁndings during follow-up, potentially leading
to adverse clinical events. Optimisation of the iliac seal zone providing a long distal seal length and added
attention to patients with large aneurysms or receiving 24 mm diameter iliac extensions are recommended.
Also, long-term surveillance including CTA is advised to reveal and correct loss of seal at the iliac attachments
before adverse clinical events occur.
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//dx.doi.org/10.1016/j.ejvs.2016.11.003INTRODUCTION
The importance of the iliac seal zones after endovascular
aneurysm repair (EVAR) is not completely understood. The
true incidence of iliac dilatation and retraction is largely
unknown, and the potential consequences e loss of seal or
occlusion e are undetermined.
While much attention over the years has focused on the
hostile proximal neck, there is a lack of evidence regarding
the risk of iliac complications that in turn may account for a
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cation of the signiﬁcance and particularities of distal sealing
zone dynamics after implantation may help reduce iliac
related complications and consequently improve clinical
success of EVAR.
There have been publications suggesting that adverse
iliac anatomy increases the risk of complications.1e6 How-
ever, difﬁculties in serial morphological assessment of iliac
arteries have resulted in a gap in perception of post-implant
iliac changes and possible complications.
This study aimed to identify the dynamics of the distal
sealing zone over time and its association with clinical
events.
METHODS
Sample
A retrospective study was conducted based on a prospec-
tively kept database of AAA patients treated by EVAR in a
single tertiary institution from 2004 to 2012. Inclusion
criteria were treatment with an endovascular device with
landing zone in the common iliac arteries and surveillance
using computed tomography angiography (CTA). Patients
with infected or anastomotic aneurysms were excluded
from the analysis. Implants with extension to the external
iliac artery were not included in the analysis. If a patient
had both common and external iliac artery sealing zones,
only the common iliac limb was considered.Measurements
All measurements were performed by two observers trained
in image analysis (FBG, NO), after manual centre lumen line
(CLL) reconstruction using dedicated post-processingFigure 1. Method for serial length and diametsoftware (3Mensio, Bilthoven, The Netherlands). According
to local practice, pre-operative CTA had to be performed no
more than 3 months before operation, and the ﬁrst post-
operative CTA was performed within 30 days (typically at
day 2 or 3, before hospital discharge). The local surveillance
protocol during the study period included annual CTA,
although a shift towards more duplex ultrasound based
surveillance was noted during the last few years.
To assess iliac dilatation in a standardised fashion, the iliac
bifurcation was used as landmark and the iliac diameter
measured a ﬁxed distance from this landmark. The ﬁrst post-
operative CTA was used as reference and the iliac diameter
was measured 10 mm proximal to the distal edge of the
implanted stent graft. The distance to the iliac bifurcation
was recorded and the pre-implantation iliac diameter was
measured at the same level. Using the same technique, the
last available post-operative iliac diameter was obtained
(Fig. 1). To assess endograft limb retraction over time, the
distance from the most distal portion of the stent graft to
the iliac bifurcation was measured at the ﬁrst and last
available exams. Validation of this technique was performed
on a random sample of 30 patients. Inter-observer agree-
ment was high (Spearman’s Rho 0.969 for iliac diameter and
0.989 for distance from graft to iliac bifurcation, Fig. 2).
Iliac seal length measuring was performed according to
previously reported methods.7 In summary, the length of
circumferential apposition between the iliac endograft and
the iliac artery wall was measured in a CLL reconstruction
(Fig. 3).
Deﬁnitions
Iliac dilatation was deﬁned as an increase greater than
2 mm or 10% of the outer to outer iliac diameter. Dilatationer measurements at the iliac sealing zone.
Figure 2. Bland-Altman plots for inter-observer variability for iliac artery diameter (left) and distance between the distal end of the
endograft and iliac artery bifurcation (right).
Iliac Seal Zone Dynamics and Clinical Consequences 187beyond implanted graft diameter was considered if the
outer to outer iliac diameter exceeded the implanted graft
diameter by 2 mm (mean wall thickness among 20 random
cases from the study population was 1.2 mm, 0.88).
Endograft retraction was considered present if the distance
between the iliac bifurcation and the distal edge of the last
stent had increased 5 mm. Oversizing was calculated us-
ing the following formula: (implanted limb diameter e
native iliac diameter)/native iliac diameter. Iliac seal com-
plications were considered if one of the following occurred:
type Ib endoleak or need for iliac limb extension (pre-
emptive). Iliac artery tortuosity was classiﬁed into 90 or
<90 based on evaluation of the pre-operative imaging.Figure 3. Method for serial measurement of iliac sealing length. CIA ¼
artery.Endpoints
The primary endpoints for this study were dilatation of the
common iliac arteries and endograft limb retraction. Addi-
tionally, the associations among iliac dilatation, limb
retraction, oversizing, and distal seal length at implant were
investigated. Lastly, the potential clinical consequences of
iliac dilatation and limb retraction were investigated.Statistical analysis
Discrete variables are presented as counts and percentages,
and continuous variables as mean  standard deviation if
normally distributed, or median (interquartile range [IQR]) ifcommon iliac artery; EIA ¼ external iliac artery, IIA ¼ internal iliac
Table 1. Baseline patient and device related characteristics.
Age, years 72.3 (7.5)
Female gender 42 (11)
Pre-operative AAA maximum
diameter, mm
61.0 (56.0e71.0)
Common iliac diameter, mm 14.0 (12.0e16.0)
Endografts used
Medtronic Endurant 322 (53.9)
Gore Excluder 238 (39.9)
Medtronic Talent 22 (3.7)
Cook Zenith 5 (0.8)
Others 12 (2.0)
AUI conﬁguration, N (%) 26 (4.3)
Implanted diameter, mm (593/597) 16.0 (14.0e20.0)
Percentage iliac oversizing (590/597) 20.0 (9.0e33.3)
Common iliac seal length @30 days
(597/597)
28.0 (19.0e38.0)
Continuous data are presented as mean (standard deviation) or
median (IQR), dichotomous data as count (percentage).
Table 2. Iliac seal dynamics over follow-up (N ¼ 597 iliac arteries).
p-Value
Pre-operative iliac diameter, mm 14.0 (12.0e16.0)
Iliac diameter at 30 days, mm 15.0 (13.0e17.0) <.001
Iliac diameter at last CTA, mm 18.0 (15.0e21.0) <.001
Iliac dilatation, mm 3.0 (1.0e5.0) <.001
4 mm 235 (39.3)
Iliac limb retraction (mm) 0.0 (2.0 to 2.0) <.001
5 mm 54 (9.1)
Continuous data are presented as median (IQR), dichotomous data
as count (percentage).
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and diameter over time were tested using related samples
Wilcoxon signed rank test. Associations between iliac artery
dilatation, endograft limb retraction, and distal seal com-
plications (type-Ib endoleaks, loss of seal without endoleak,
or need for iliac extension) and morphological and device
related variables were tested using Mann-Whitney U sta-
tistics for continuous non-normal data or with the Pearson’s
chi-square for categorical variables. Multivariate logistic
regression models were created for each outcome with
variables with an a value .1 after excluding multi-
collinearity among the included variables. Time was
included as a covariate in the models to adjust for the
differences in timing of last available CT imaging. An a value
<.05 was considered to be statistically signiﬁcant. All sta-
tistical analyses were performed using SPSS software v20.
RESULTS
Four-hundred and ﬁfty two patients were treated with
EVAR from 2004 to 2012 at the Erasmus Medical Centre. Of
these, eight had infected aneurysms, 38 had anastomotic
aneurysms and one was a traumatic aneurysm. From the
remaining 405 patients, another 64 were excluded because
they did not have two post-operative CTAs of which one
within 30 days of operation for comparison of iliac
morphology. Three hundred and forty one patients (26
aortic-uni-iliac devices, 656 iliac arteries overall) followed
for a median of 4.7 years (IQR 2.8e6.2) were included.
Among these, there were 59 cases of endograft extensions
ending in the external iliac artery that were excluded,
leaving 597 common iliac arteries available for analysis.
Baseline characteristics
The mean age of the study population was 72.3  7.5 years,
and there were 41 (11%) females. The median pre-operative
AAA diameter was 61 mm (IQR 56e71), and the median
iliac diameter was 14 mm (IQR 12e16). The median iliac
oversizing chosen for device implantation was 20% (IQR 9e
33). A variety of devices were used in this patient cohort,
with predominance of the Medtronic Endurant (189/341,
55.4%) and Gore Excluder (130/341, 38.1%) devices. AUI
devices were used in 26/341 (7.6%) patients. Baseline
characteristics are summarised in Table 1.
Iliac dilatation and limb retraction
At the 30 day CTA, the median distance from the distal edge
of the endograft to the iliac bifurcation was 21 mm (IQR
14e31), and the median iliac seal length was 28 mm (IQR
19e38). The median iliac diameter, measured 10 mm
proximal to the distal edge of the implant, increased from
14 mm to 15 mm (p < .001) at 30 day imaging and to
18 mm (p < .001) at the last available CT (Table 2). At the
last available imaging, iliac dilatation was 20% in 295
cases (49.4%) and had exceeded the implanted endograft
diameter at the measuring point in 170 cases (28.7%).
Among patients treated with 24 mm diameter endografts,
median iliac dilatation was 4.0 mm (17.8%) (IQR 7.6e37.0%) while for the remaining patients it was 3.0 mm
(19.9%) (IQR 6.7e33.3%) (p ¼ .96). Follow-up time (OR
1.69, 95% CI 1.53e1.86) and oversizing >20% (OR 2.61,
95% CI 1.77e3.86, Table 3) were identiﬁed in multivariate
regression analysis as independent risk factors for dilatation
20%. In multivariate analysis, the chance of the iliac artery
diameter exceeding the diameter of the implanted endog-
raft increased over time (OR 1.42 per year, 95% CI 1.30e
1.56, p < .001) and was higher among patients with iliac
limb retraction 5 mm (OR 2.02, 95% CI 1.07e3.80,
p ¼ .03). On the other hand, endograft oversizing 15%
was protective for excessive dilatation (OR 0.52, 95% CI
0.35e0.77, p ¼ .001).
Retraction 5 mm was observed in 54 (9.1%) cases.
Implantation of a 24 mm endograft limb (OR 2.80, 95% CI
1.44e5.46) and iliac artery dilatation (OR 1.09 per mm, 95%
CI 1.01e1.18) were found to be independent risk factors for
retraction 5 mm (Table 4).
The endograft model was signiﬁcantly associated with
retraction 5 mm, occurring in 41 cases (11.9%) with
Medtronic devices and in 13 cases (5.5%) with Gore devices
(p ¼ .008). No association was found regarding dilatation.
Predictors of iliac seal complications
Iliac seal complications occurred in 34 (5.7%) of the cases
(Table 5): there were 16 (2.7%) type 1B endoleaks of which
seven had retraction 5 mm, and a single case of a type 3
Table 3. Uni and multivariate associations for iliac artery dilatation 20%.
Risk factor Univariate Multivariate
Dilatation 20% (N ¼ 295) Controls (N ¼ 302) p-Value OR 95% CI p-Value
CT follow-up, years 4.4 (2.9e5.5) 1.8 (0.2e3.6) <.001 1.69 1.53e1.86 <.001
Pre-operative AAA diameter 60.0 (55.0e72.0) 62.0 (56.0e71.0) .237
Pre-operative iliac artery diameter 14.0 (12.0e16.0) 14.0 (12.0e16.0) .376
Pre-operative iliac artery tortuosity 90 57 (19.3) 34 (11.3) .007 1.39 0.81e2.38 .235
Endograft diameter 24 35 (11.9) 39 (12.9) .664
Oversizing >20% 165 (56.5) 124 (41.1) <.001 2.61 1.77e3.86 <.001
Iliac seal @30 days 20 mm 82 (27.8) 97 (32.4) .217 0.83 0.55e1.26 .384
Distance to iliac bifurcation @30 days 20.0 (13.0e30.0) 22.0 (15.0e33.0) .070
Iliac limb retraction 5 mm 29 (9.8) 25 (8.3) .553 1.26 0.65e2.43 .489
Continuous data are presented as median (IQR), dichotomous data as count (percentage).
Table 5. Iliac seal complications and related secondary
interventions.
Complications N (%)
Type 1B endoleak 16 (2.7)
Type 3 endoleak 1 (0.2)
Sac growth without visible endoleak 7 (1.2)
Secondary interventions
Iliac limb extensions 29 (4.9)
Pre-emptive limb extension because of loss of
seal but without type 1B endoleak
17 (2.9)
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detectable type IB or III endoleak. In two cases the endoleak
was present at the 30 day CTA, all the rest developed later.
Aneurysm rupture occurred in a patient with bilateral type
1B endoleaks and who was later found to have also
developed a type 1A endoleak. The patient was considered
unﬁt for open conversion, and the anatomy was very
unfavourable for endovascular treatment, so no elective
correction was proposed. The patient subsequently died
because of rupture. In 17 patients (2.9%) a pre-emptive
limb extension was performed because of loss of seal,
without a visible endoleak. No model of endograft was
associated with an increased rate of seal complications.
There were 75 iliac arteries implanted with a24 mm iliac
endograft. Seal related complications developed in eight of
these (10.7%)while therewere 26events in the remaining 522
iliac limbs receiving an endograft<24 mm of diameter (5.0%,
p¼ .047). Iliac limb occlusion occurred in one case among the
24 mm iliac limb group (1.3%) while it developed in nine
cases among the <24 mm iliac limb group (1.9%, p ¼ .17).
Among patients with iliac seal complications, median iliac
dilatation 3.5 mm (1e6.1) and median retraction was
3.5 mm (0e8.5). Dilatation beyond the graft diameter was
present in 11 (32%) cases, and retraction >5 mm in 13
(38.2%, Table 5).Table 4. Uni- and multivariate associations for limb retraction 5 mm
Risk factor Univariate
Limb retraction
5 mm (N ¼ 54)
W
(
CT follow-up time, years 3.1 (1.5e5.0) 3
Pre-operative AAA diameter, mm 62.0 (56.0e76.3) 6
Pre-operative iliac diameter, mm 15.5 (13.0e17.5) 1
Pre-operative iliac artery tortuosity 90 12 (22.2) 8
Iliac endograft diameter 24 mm 15 (27.8) 6
Oversizing (%) 17.7 (12.4e28.9) 2
Iliac seal @30 days, mm 28.5 (20.0e41.3) 2
Distance between graft and iliac bifurcation
@ 30 days, mm
21.0 (11.8e30.3) 2
Iliac artery dilatation beyond endograft 23 (42.6) 1
Iliac limb occlusion 0 (0.0) 1
Continuous data are presented as median (IQR), dichotomous data as
a Multicollinearity was detected between pre-operative iliac diamet
consequently the former variable was excluded from the multivariateUnivariate analysis of possible risk factors for iliac seal
complications revealed baseline AAA diameter (p ¼ .018),
baseline iliac diameter (p ¼ .037), iliac endograft diameter
24 mm (p ¼ .047), iliac seal length at 30 days (p < .001),
distance from the distal end of the iliac limb to the iliac
artery bifurcation (p ¼ .01), and iliac limb retraction
(p < .001) as signiﬁcant (Table 6).
The degree of oversizing was not associated with seal
complications in this cohort. Multivariate analysis, adjusted
for duration of follow-up, conﬁrmed pre-operative AAA
diameter (1.04 per mm increase, 95% CI 1.01e1.07) and iliac
limb retraction (OR 1.17 per mm increase, 95% CI 1.10e
1.24) as independent risk factors for iliac seal complications.
Iliac seal length on 30 day imaging was a protective factor.
Multivariate
ithout complication
N ¼ 543)
p-Value OR 95% CI p-Value
.1 (1.2e5.0) .429
1.0 (55.0e71.0) .352
4.0 (12.0e16.0) .001a _ e e
0 (14.7) .146
0 (11.0) <.001 3.31 1.71e6.44 .003
1.7 (9.1e33.3) .597
8.0 (18.0e38.0) .211
1.0 (14.0e32.0) .477
47 (27.3) .018 2.14 1.20e3.84 .010
0 (1.8) .315
count (percentage).
er and device size (Pearson’s correlation R ¼ .737, p < .001),
model.
190 F. Bastos Gonçalves et al.for iliac seal complications (OR 0.94 per mm increase, 95% CI
0.90e0.97).
Among the 34 cases of seal complications, 29 of these
underwent a limb extension of which 17 were performed
pre-emptively. In ﬁve cases, a type 1A endoleak developed
subsequently either before treatment (2 cases, same pa-
tient) or after successful intervention (limb extension, 3
cases). Additional proximal seal related endovascular pro-
cedures were performed in the latter three cases.DISCUSSION
After EVAR, the iliac sealing zone remains dynamic and is a
possible source of morbidity and, ultimately, treatment
failure. Although attention has focused on the proximal
seal, the present study suggests that iliac dilatation and
endograft limb retraction are common occurrences and are
associated with clinical consequences.
Much of the difﬁculty in reporting iliac related compli-
cations is related to the capacity for accurately assessing
and reproducing measurements. Reporting measurements
on the proximal attachment site can be done using well-
standardised methods. In contrast, the complexity of the
iliac sealing zones probably explains the lack of stand-
ardisation for reporting and consequently the paucity and
conﬂicting nature of published data.8 In this study, a tech-
nique is proposed, based on centre lumen line measure-
ments and anatomical landmarks, which allows for
consecutive measurements of the distal iliac seal zone at
exactly the same location, as well as quantiﬁcation of the
retraction of iliac components of endografts. Using this tool,
it was possible to demonstrate that both iliac dilatation and
endograft limb retraction are common and related events.
Moreover, limb retraction is a risk factor for iliac seal
complications. Importantly, the length of the initial iliac seal
achieved during endograft implantation is the only protec-
tive factor for seal complications.
Iliac dilatation over time has been demonstrated before.
Kaladji et al. studied the evolution of 179 patients over aTable 6. Uni- and multivariate associations for sealing complications.
Risk factor Univariate
With seal
complication (N ¼ 34)
Follow-up time, years 6.8 (5.0e9.0)
Pre-operative AAA diameter, mm 70 (58.5e83.5)
Pre-operative iliac diameter, mma 18.0 (16.0e24.0)
Pre-operative iliac artery tortuosity 90 13 (38.2)
Iliac endograft diameter 24 mm 8 (23.5)
Oversizing (%) 20.0 (9.0e41.0)
Iliac seal @30 days, mm 17.5 (5.0e26.0)
Distance between graft and iliac bifurcation
@ 30 days, mm
29.0 (16.8e38.5)
Iliac artery dilatation beyond endograft 11 (32.4)
Iliac limb retraction, mm 3.5 (0e8.3)
Iliac limb occlusion 0 (0)
Continuous data are presented as median (IQR), dichotomous data as
a Multicollinearity was detected between pre-operative iliac diamet
consequently the former variable was excluded from the multivariatemean of 24 months, and found iliac dilatation to be very
common (mean increase 2e3 mm, depending on level).
Although they could not ﬁnd a correlation with clinical
events, the authors sent a word of caution.2 Previously,
Falkensammer et al. had shown that dilatation was more
pronounced in patients with previously existing iliac dila-
tation,9 and both Hobo et al. and Albertini et al. reported a
higher risk of complications in patients requiring bell-
bottom (24 mm) iliac limbs, a ﬁnding corroborated by
the present study.6,10 Similarly, Schanzer et al. reported a
greater chance of sac enlargement in patients with larger
(20 mm or greater) iliac diameter endografts.11 In the
present study, although iliac arteries receiving a bell-bottom
endograft did not dilate more than the remaining cases,
signiﬁcantly more limb retraction was observed among this
group, which is, in the authors’ opinion, the preceding step
to development of a seal complication. Furthermore, the
present study suggests that progressive iliac dilatation,
which starts immediately following EVAR, precedes limb
retraction, which in turn is a risk factor for clinically signif-
icant iliac seal loss, thus establishing a temporal line be-
tween these events. According to the present results, iliac
dilatation follows two stages, one acute immediately post-
implant and another gradually occurring over time. This
reproduces the phenomenon already well characterised at
the proximal aneurysm neck, following implantation of
oversized self expanding nitinol based devices.12 Although
uncommon at the proximal neck, expansion beyond the
diameter of the implanted endograft is not a rare event in
the iliac arteries during follow-up, as shown by Adiseshiah
et al.13 and conﬁrmed in this study. Although the present
study reports a high rate (28.7%) of iliac artery dilatation
greater than the diameter of the endograft, iliac seal
complications were only noted in 5.7%, as the iliac seal was
still conserved over some of the remaining length of the
iliac artery. Of note, excessive oversizing did increase the
risk of excessive dilatation over time, which is a logical
ﬁnding because of the self expanding nature of the
implanted nitinol material. However, excessive oversizingMultivariate
Without seal
complication (N ¼ 563)
p-Value OR 95% CI p-Value
4.6 (2.7e6.1) <.001 1.49 1.26e1.77 <.001
61 (55e71) .018 1.04 1.01e1.07 .006
14.0 (12.0e16.0) .037a e e e
79 (13.2) <.001 1.44 0.59e3.52 .428
67 (11.9) .047 2.54 0.89e7.27 .081
20.0 (9.0e33.0) .908
29.0 (20.0e38.0) <.001 0.94 0.90e0.97 <.001
21.0 (13.0e31.0) .01 1.02 0.99e1.05 .119
159 (28.4) .625
0.0 (2.0 to 2.0) <.001 1.17 1.10e1.24 <.001
10 (1.8) .433
count (percentage).
er and device size (Pearson’s correlation R ¼ .737, p < .001),
model.
Iliac Seal Zone Dynamics and Clinical Consequences 191did not, in the present series, result in further or acceler-
ated degeneration beyond the implanted diameter, which
explains why this is not a predictor of complications.
Nevertheless, the iliac seal zone will most likely remain
dynamic over time, possibly leading to complete loss of seal
and the development of a type 1B endoleak and leaving a
signiﬁcant number of patients at increased chance of
rupture. Consequently, the present authors recommend
that increasing the distal seal length at the original im-
plantation may be an adequate preventive measure.
Iliac limb retraction is an interesting and relevant ﬁnding
of this study. Sideways displacement of endograft limbs
within the aneurysm sac has been associated with adverse
events after EVAR.14 This observation may be a surrogate
ﬁnding of limb retraction (in the absence of endograft
migration in the proximal aneurysm neck and inadequate
component overlap). In fact, Waasdorp et al.14 found that
patients with limb displacement had larger aneurysms and
shorter iliac ﬁxation zones, ﬁndings consistent with the re-
sults of the present study. This study demonstrates that iliac
retraction is a common event, associated with iliac dilata-
tion, which is likely to reduce the resistance to displacement
resulting from the endografts’ radial force. This effect had
been suggested before by Arko et al., in an in vitro study
evaluating the importance of iliac ﬁxation in preventing
longitudinal displacement of a stent graft.15 Moreover, the
present study suggests that iliac arteries requiring a bell-
bottom endograft are more prone to develop limb retrac-
tion, which in turn increases the risk of developing an iliac
seal related complication. And despite reaching only a sta-
tistical trend on multivariate modelling for iliac seal
complication prediction, the observed rate of iliac seal
complications was double among bell-bottom iliac limbs
when compared with the remaining cases, and, as previ-
ously stated, the risk of endograft retraction was threefold
in these cases, when compared with the smaller diameter
arteries. Benharash et al. later found, in a study analysing
92 patients treated between 2000 and 2004, that shorter
iliac ﬁxation length was associated with the risk of proximal
device migration, and suggested coverage of the entire
length of the common iliac artery as a protective factor.16
Others have also linked the chance of retraction to insufﬁ-
cient distal seal.17,18 Although most of the studied endog-
rafts in these studies had a high columnar force (AneuRx),
which had previously been regarded to be more prone to
presenting iliac seal complications, these events have also
been reported among devices with highly ﬂexible limbs
other than in the present report.19 Consequently, it is rec-
ommended to increase the length of iliac seal to reduce the
risk of iliac seal complications, regardless of the speciﬁc
endograft model.
There are important limitations to this study that must be
considered. Firstly, there is a bias in patient and graft se-
lection that limits the extrapolation of these results to all
EVAR populations. In particular, there is a paucity of pa-
tients treated with devices with stiffer iliac components.
These may yield different results in terms of the chance of
retraction and/or occlusion, and change the resultssigniﬁcantly. This study used predominantly Medtronic and
Gore devices, and although a higher risk was found for
retraction with the use of Medtronic devices, this is most
likely explained by the selection bias introduced with larger
device diameters being available for that speciﬁc manu-
facturer. The exclusion of patients with extension to the
external iliac also restricts the applicability of the results,
but allowed for a more homogeneous sample and meth-
odology. Another limitation is the relatively few clinical
events in the present series, which limits the capacity for
discriminating risk factors and therefore to make stronger
recommendations on minimal seal or ideal oversizing to
reduce the rate of adverse clinical events. Also, the retro-
spective design of the study has the potential risk of se-
lection bias. Finally, the method used to determine iliac
morphology and dynamics, although highly reproducible, is
relatively complex and may not be practical for use in a
clinical setting.
Despite the limitations, three recommendations can be
made based on these results. Firstly, the authors suggest
maximisation of the iliac seal zone by adapting the planning
to increase the wall-graft contact length and extending the
iliac components as close as possible to the iliac bifurcation.
This recommendation which was made in the era of much
stiffer endografts seems to remain valid for the current
ﬂexible ones. This is particularly important, in patients with
large AAA (65 mm diameter) or patients requiring iliac
endograft extensions with 24 mm diameters. An increase
in seal may be achieved by simply extending the larger
diameter limb length, instead of sealing only at the ﬁnal
stent component of the graft. In patients where an
adequate iliac seal (>15 mm) cannot be achieved, exten-
sion to the external iliac artery may be considered, possibly
with preservation of the internal iliac artery (with an iliac
bifurcated device or other revascularisation methods) when
technically feasible and clinically justiﬁed. While technical
success is generally very high when extending to the
external iliac artery (with or without hypogastric side
branch), this increases the risk of occlusion by over 50%
especially if the vessel diameter is <10 mm.20 Moreover,
hypogastric branch devices occlude frequently, both early
and at midterm.21,22 In the absence of clear recommenda-
tions, clinical judgement should consider the risk of endo-
leak by sub-optimal seal at the common iliac artery and
balance this with the increased risk of occlusion when
extending to the external iliac artery.
Secondly, the present data suggest that oversizing by 15%
or greater at the distal component is recommended for
prevention of seal complications. However, excessive over-
sizing is a known risk factor for occlusion and this endpoint
was not considered in this study,23,24 therefore, a maximum
safe oversizing cannot be recommended.
Thirdly, extra attention should be given to surveillance of
patients with large aneurysms and endograft limbs
24 mm, especially in the long term. As CT is necessary to
determine progressive loss of seal and/or retraction, it is
suggested that these patients should have a surveillance
programme that includes CT scanning at least occasionally.
192 F. Bastos Gonçalves et al.As dilatation and retraction is a late phenomenon, CT scans
cannot be waived completely over time.
In conclusion, this study demonstrates that the iliac seal
zone remains dynamic after EVAR implantation. Iliac dila-
tation and endograft limb retraction are common ﬁndings
during follow-up, which may lead to clinically relevant loss
of iliac seal. Optimisation of the iliac seal zone providing
long distal seal length and added attention to patients with
large aneurysms and those receiving 24 mm diameter iliac
endograft extensions are recommended. Also, long-term
surveillance including CTA is advised to reveal and correct
loss of seal at the iliac attachments before adverse clinical
events occur.
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